np event 2254995 0E193A 1
Dec 15, 2025
- Dec 14, 2026
Updating the Efficacy and Safety Experience of IL-17 Inhibitors
0.75

Claim your AMA PRA Category 1 Credits or CNE Contact Hours

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Group 39553
Dermatology
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
np document 888746 0E193A 5
Rheumatology
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patient...
np document 888746 0E193A 5
Neurology
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Th...